Erlotinib
CAS No. 183321-74-6
Erlotinib ( NSC-718781;OSI-744;R-1415;CP-358774 )
Catalog No. M12829 CAS No. 183321-74-6
A potent, selective inhibitor of EGFR with IC50 of 2 nM; reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 36 | In Stock |
|
100MG | 43 | In Stock |
|
500MG | 65 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameErlotinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective inhibitor of EGFR with IC50 of 2 nM; reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM.
-
DescriptionA potent, selective inhibitor of EGFR with IC50 of 2 nM; reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM; inhibits the proliferation of DiFi human colon tumor cells at submicromolar concentrations in cell culture and blocks cell cycle progression at the G1 phase; 100mg/kg completely prevents EGF-induced autophosphorylation of EGFR in human HN5 tumors growing as xenografts in athymic mice and of the hepatic EGFR of the treated mice; orally active.Lung Cancer Approved
-
SynonymsNSC-718781;OSI-744;R-1415;CP-358774
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research AreaCancer
-
IndicationLung Cancer
Chemical Information
-
CAS Number183321-74-6
-
Formula Weight393.44
-
Molecular FormulaC22H23N3O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCOCCOC1=C(OCCOC)C=C2C(NC3=CC=CC(=C3)C#C)=NC=NC2=C1
-
Chemical Name4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ng SS, et al. Mol Cancer Ther. 2002 Aug;1(10):777-83.
2. Moyer JD, et al. Cancer Res. 1997 Nov 1;57(21):4838-48.
3. Pollack VA, et al. J Pharmacol Exp Ther. 1999 Nov;291(2):739-48.
2. Moyer JD, et al. Cancer Res. 1997 Nov 1;57(21):4838-48.
3. Pollack VA, et al. J Pharmacol Exp Ther. 1999 Nov;291(2):739-48.
molnova catalog
related products
-
Mobocertinib
Mobocertinib is a potent ?inhibitor of epidermal growth factor receptor (EGFR) and an antineoplastic agent.
-
FRAX597
FRAX597 is an effective, ATP-competitive inhibitor of group I PAKs, and for PAK1(IC50=8 nM), PAK2(IC50=13 nM), and PAK3 (IC50=19 nM).
-
AZ5104
AZ5104, the demethylated metabolite of AZD-9291, is a potent EGFR inhibitor.